Skip to main content


We're creating a new version of this page. See preview

  • Correction
  • Open Access

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation

  • 1, 2,
  • 1,
  • 1,
  • 1,
  • 1, 3,
  • 1,
  • 1,
  • 4,
  • 4 and
  • 1, 5, 6Email author
Multiple Sclerosis and Demyelinating Disorders20194:3

  • Received: 22 February 2019
  • Accepted: 22 February 2019
  • Published:

The original article was published in Multiple Sclerosis and Demyelinating Disorders 2017 2:3

Correction to: Multiple Sclerosis and Demyelinating Disorders (2017) 2:3.

After publication of the article [1], it has been brought to our attention that the full funding acknowledgement is missing from the original article. It should also include the following –

“This work was supported by the Instituto de Salud Carlos III with FEDER funds (Otra forma de hacer Europa) from the European Commission (FIS: PI12/01823)”.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Center of Neuroimmunology, Institut d’Investigacions Biomediques August Pi Sunyer (IDIBAPS), Barcelona, Spain
Department of Basic Sciences, Facultad de Medicina i Ciències de la Salut, Universitat International de Catalunya (UIC), Sant Cugat del Vallés, Spain
Neurogenomiks, University of Basque Country, Leioa, Spain
University of Barcelona, Barcelona, Spain
University of California, San Francisco, USA
Centre Cellex 3A, Casanova 145, 08036 Barcelona, Spain


  1. Moreno B, Vila G, Fernandez-Diez B, Vázquez R, di Penta A, Errea O, et al. Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Multiple Sclerosis and Demyelinating Disorders. 2017;2(1).Google Scholar


© The Author(s). 2019